Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

In vivo dendritic cell reprogramming for cancer immunotherapy [organoid scRNA]

ABSTRACT: In vivo dendritic cell reprogramming for cancer immunotherapy [organoid scRNA]

PROVIDER: PRJNA1075314 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27937339_1.fastq.gz	Fastqsanger.gz
	SRR27937339_2.fastq.gz	Fastqsanger.gz
	SRR27937340_1.fastq.gz	Fastqsanger.gz
	SRR27937340_2.fastq.gz	Fastqsanger.gz
	SRR27937341_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 40

Similar Datasets

In vivo dendritic cell reprogramming for cancer immunotherapy [organoid scRNA]

Project description:Immunotherapy can lead to long-term survival for some cancer patients, yet generalized success has been hampered by insufficient antigen presentation and exclusion of immunogenic cells from the tumor microenvironment. Here, we developed an approach to reprogram tumor cells in vivo by adenoviral delivery of the transcription factors PU.1, IRF8, and BATF3, which enabled them to present antigens as type 1 conventional dendritic cells. Reprogrammed tumor cells remodeled their tumor microenvironment, recruited, and expanded polyclonal cytotoxic T cells, induced tumor regressions, and established long-term systemic immunity in multiple mouse melanoma models. In human tumor spheroids and xenografts, reprogramming to immunogenic dendritic-like cells progressed independently of immunosuppression, which usually limits immunotherapy. Our study paves the way for human clinical trials of in vivo immune cell reprogramming for cancer immunotherapy.

2024-09-05 | GSE255536 | GEO

In vivo dendritic cell reprogramming for cancer immunotherapy [T cell scRNA + TCR]

Project description:In vivo dendritic cell reprogramming for cancer immunotherapy [T cell scRNA + TCR]

| PRJNA1074791 | ENA

In vivo dendritic cell reprogramming for cancer immunotherapy [T cell scRNA + TCR]

2024-09-05 | GSE255385 | GEO

Single-cell transcriptome atlas of human retinal organoid development

Project description:In order to provide multi-omic resolution to human retinal organoid developmental dynamics, we performed scRNA-seq and scATAC-seq from the same cell suspension across a time course (6-46 weeks) of human retinal organoid development. This data set covers all the retinal organoid scRNA-seq data generated from IMR90 and409B2-iCas9 cell lines.

2023-03-12 | E-MTAB-12715 | biostudies-arrayexpress

Treatment of dendritic cells and monocytes from immunotherapy treated patients with ONTAK

Project description:In this experiment, dendritic cells and monocytes obtained from melanoma patients who underwent immunotherapy were stimulated with a maturation cocktail then either treated or not treated with denlieukin diftitox (DD; ONTAK) and then subjected to transcription profiling to investigate the effects of DD on the maturation and activation of dendritic cells and monocytes.

2013-09-04 | E-MTAB-977 | biostudies-arrayexpress

Restoring Tumor Immunogenicity with Dendritic Cell Reprogramming [scRNA-seq]

Project description:Restoring Tumor Immunogenicity with Dendritic Cell Reprogramming [scRNA-seq]

| PRJNA934540 | ENA

Single-cell chromatin accessibility atlas of human retinal organoid development

Project description:In order to provide multi-omic resolution to human retinal organoid developmental dynamics, we performed scRNA-seq and scATAC-seq from the same cell suspension across a time course (6-46 weeks) of human retinal organoid development. This data set covers all the retinal organoid scATAC-seq data generated from IMR90 and 409B2-iCas9 cell lines.

2023-03-12 | E-MTAB-12714 | biostudies-arrayexpress

Restoring Tumor Immunogenicity with Dendritic Cell Reprogramming

Project description:Restoring Tumor Immunogenicity with Dendritic Cell Reprogramming

| PRJNA933158 | ENA

Cytokine-armored dendritic cell progenitors for antigen-agnostic cancer immunotherapy

Project description:Cytokine-armored dendritic cell progenitors for antigen-agnostic cancer immunotherapy

| PRJNA948418 | ENA

p38MAPKa stromal reprogramming sensitizes metastatic breast cancer to immunotherapy

Project description:p38MAPKa stromal reprogramming sensitizes metastatic breast cancer to immunotherapy

| PRJNA865030 | ENA